Want to join the conversation?
Based on its strong 3Q16 results, $ABC raised its FY16 earnings outlook to $5.52 to $5.57 per share from its previous outlook of $5.44 to $5.54 per share. $ABC added that it expects 4Q16 gross profit to remain under pressure due to weaker generic pricing trends as well as lower contributions from new generic drugs.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.